{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:26:25Z","timestamp":1789140385432,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejrad.2023.110926","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T03:33:25Z","timestamp":1686886405000},"page":"110926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses"],"prefix":"10.1016","volume":"165","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-7184","authenticated-orcid":false,"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejrad.2023.110926_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110926_b0010","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA: Cancer J. Clin."},{"issue":"10290","key":"10.1016\/j.ejrad.2023.110926_b0015","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.ejrad.2023.110926_b0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/uog.5365","article-title":"Simple ultrasound-based rules for the diagnosis of ovarian cancer","volume":"31","author":"Timmerman","year":"2008","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"17","key":"10.1016\/j.ejrad.2023.110926_b0025","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-16-3248","article-title":"Clinical utility of risk models to refer patients with adnexal masses to specialized oncology care: multicenter external validation using decision curve analysis","volume":"23","author":"Wynants","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejrad.2023.110926_b0030","doi-asserted-by":"crossref","first-page":"673722","DOI":"10.3389\/fonc.2021.673722","article-title":"Comparison of the diagnostic performances of ultrasound-based models for predicting malignancy in patients with adnexal masses","volume":"11","author":"Qian","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110926_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijgo.12891","article-title":"Comparison of the diagnostic accuracy of International Ovarian Tumor Analysis simple rules and the risk of malignancy index to discriminate between benign and malignant adnexal masses","volume":"146","author":"Auekitrungrueng","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110926_b0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2014.333","article-title":"Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study","volume":"111","author":"Testa","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejrad.2023.110926_b0045","doi-asserted-by":"crossref","unstructured":"J.Y. An, K.M.L. Unsdorfer, J.C. Weinreb, BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: reporting and data systems, radiographics: a review publication of the Radiological Society of North America, Inc 39(5) (2019) 1435\u20131436, doi: 10.1148\/rg.2019190087.","DOI":"10.1148\/rg.2019190087"},{"issue":"10","key":"10.1016\/j.ejrad.2023.110926_b0050","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jacr.2018.07.004","article-title":"Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR ovarian-adnexal reporting and data system committee","volume":"15","author":"Andreotti","year":"2018","journal-title":"J. American College of Radiology: JACR"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2019191150","article-title":"O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee","volume":"294","author":"Andreotti","year":"2020","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110926_b0060","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI110380","article-title":"Reactivity of a monoclonal antibody with human ovarian carcinoma","volume":"68","author":"Bast","year":"1981","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110926_b0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajog.2008.04.009","article-title":"The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?","volume":"199","author":"Nossov","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110926_b0070","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ejrad.2023.110926_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.029","article-title":"Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders","volume":"206","author":"Moore","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0080","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1038\/s41598-021-96552-9","article-title":"Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis","volume":"11","author":"Suri","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejrad.2023.110926_b0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2009.09.041","article-title":"Current state of biomarker development for clinical application in epithelial ovarian cancer","volume":"116","author":"Moore","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.ejrad.2023.110926_b0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejrad.2023.110926_b0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2014.11.015","article-title":"ROMA, an algorithm for ovarian cancer","volume":"440","author":"Chudecka-G\u0142az","year":"2015","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"11","key":"10.1016\/j.ejrad.2023.110926_b0110","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ejrad.2023.110926_b0115","unstructured":"T. F.A., D. P., Tumours of the breast and female genital organs, World Health Organization Classification of Tumours: Pathology and Genetics, World Health Organization, Lyon, 2003, available online: https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr788, (accessed on 17 December 2022)."},{"key":"10.1016\/j.ejrad.2023.110926_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6839","article-title":"Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group","volume":"341","author":"Timmerman","year":"2010","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110926_b0125","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/uog.20163","article-title":"Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk","volume":"53","author":"Hidalgo","year":"2019","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0130","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2013.04.003","article-title":"A multicenter prospective external validation of the diagnostic performance of IOTA simple descriptors and rules to characterize ovarian masses","volume":"130","author":"Sayasneh","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ejrad.2023.110926_b0135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/uog.15854","article-title":"External validation of IOTA simple descriptors and simple rules for classifying adnexal masses","volume":"48","author":"Alc\u00e1zar","year":"2016","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110926_b0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/uog.11177","article-title":"Clinically oriented three-step strategy for assessment of adnexal pathology","volume":"40","author":"Ameye","year":"2012","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ejrad.2023.110926_b0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/uog.13437","article-title":"Use of IOTA simple rules for diagnosis of ovarian cancer: meta-analysis","volume":"44","author":"Nunes","year":"2014","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"44","key":"10.1016\/j.ejrad.2023.110926_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22440","article-title":"Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis","volume":"22","author":"Westwood","year":"2018","journal-title":"Health Technol. Assess. (Winchester, England)"},{"issue":"4","key":"10.1016\/j.ejrad.2023.110926_b0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/uog.12485","article-title":"IOTA simple rules for discriminating between benign and malignant adnexal masses: prospective external validation","volume":"42","author":"Alc\u00e1zar","year":"2013","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0160","doi-asserted-by":"crossref","first-page":"56.e1","DOI":"10.1016\/j.ajog.2019.07.031","article-title":"Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses","volume":"222","author":"Gentry-Maharaj","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejrad.2023.110926_b0165","doi-asserted-by":"crossref","unstructured":"S.F. Ngu, Y.K. Chai, K.M. Choi, T.W. Leung, J. Li, G.S.T. Kwok, M.M.Y. Chu, K.Y. Tse, V.Y.T. Cheung, H.Y.S. Ngan, K.K.L. Chan, Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple Rules, Cancers 14(3) (2022), doi: 10.3390\/cancers14030810.","DOI":"10.3390\/cancers14030810"},{"issue":"5","key":"10.1016\/j.ejrad.2023.110926_b0170","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/uog.24777","article-title":"Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women","volume":"59","author":"Hiett","year":"2022","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13048-022-00947-9","article-title":"Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses","volume":"15","author":"Xie","year":"2022","journal-title":"J. Ovar. Res."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1148\/radiol.211868","article-title":"External validation of O-RADS US risk stratification and management system","volume":"304","author":"Hack","year":"2022","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.ejrad.2023.110926_b0185","doi-asserted-by":"crossref","first-page":"7854","DOI":"10.1007\/s00330-022-08803-6","article-title":"Comparison of the O-RADS and ADNEX models regarding malignancy rate and validity in evaluating adnexal lesions","volume":"32","author":"Chen","year":"2022","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2021.04.031","article-title":"Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): analysis on 1054 adnexal masses","volume":"162","author":"Cao","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2023.110926_b0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16370","article-title":"Diagnostic performance of the ovarian-adnexal reporting and data system (O-RADS) ultrasound risk score in women in the United States","volume":"5","author":"Jha","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.211367","article-title":"Deep learning prediction of ovarian malignancy at US compared with O-RADS and expert assessment","volume":"304","author":"Chen","year":"2022","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejrad.2023.110926_b0205","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00330-020-07143-7","article-title":"Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses","volume":"31","author":"Basha","year":"2021","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1148\/radiol.213128","article-title":"O-RADS US: a retrospective assessment of prediction of malignancy in a high-risk setting","volume":"304","author":"Levine","year":"2022","journal-title":"Radiology"},{"key":"#cr-split#-10.1016\/j.ejrad.2023.110926_b0215.1","doi-asserted-by":"crossref","unstructured":"A. Knafel, T. Banas, A. Nocun, M. Wiechec, R. Jach, A. Ludwin, M. Kabzinska-Turek, M. Pietrus, K. Pitynski, The Prospective External Validation of International Ovarian Tumor Analysis (IOTA) Simple Rules in the Hands of Level I and II Examiners, Ultraschall in der Medizin (Stuttgart, Germany: 1980) 37","DOI":"10.1055\/s-0034-1398773"},{"key":"#cr-split#-10.1016\/j.ejrad.2023.110926_b0215.2","doi-asserted-by":"crossref","unstructured":"(5) (2016) 516-523, doi: 10.1055\/s-0034-1398773.","DOI":"10.1055\/s-0034-1398773"},{"key":"#cr-split#-10.1016\/j.ejrad.2023.110926_b0220.1","doi-asserted-by":"crossref","unstructured":"E. Meys, I. Rutten, R. Kruitwagen, B. Slangen, S. Lambrechts, H. Mertens, E. Nolting, D. Boskamp, T. Van Gorp, Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort Study, Ultraschall in der Medizin (Stuttgart, Germany: 1980) 38","DOI":"10.1055\/s-0043-113819"},{"key":"#cr-split#-10.1016\/j.ejrad.2023.110926_b0220.2","doi-asserted-by":"crossref","unstructured":"(6) (2017) 633-641, doi: 10.1055\/s-0043-113819.","DOI":"10.1055\/s-0043-113819"},{"issue":"1","key":"10.1016\/j.ejrad.2023.110926_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/uog.13254","article-title":"Interobserver agreement in describing adnexal masses using the International Ovarian Tumor Analysis simple rules in a real-time setting and using three-dimensional ultrasound volumes and digital clips","volume":"44","author":"Ruiz de Gauna","year":"2014","journal-title":"Ultras. Obstet. Gynecol.: Off. J. Int. Soc. Ultras. Obstet. Gynecol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23002401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X23002401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:42:11Z","timestamp":1759995731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X23002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"alternative-id":["S0720048X23002401"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110926","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2023.110926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110926"}}